-
Mashup Score: 1VJHemOnc โ The video journal of hematological oncology - 6 hour(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0IPIG 2025 | VJHemOnc - 1 day(s) ago
The 2nd International PNH Interest Group (IPIG) Conference is taking place in Paris, France, on May 15-16, 2025. This meeting will bring together leading experts in the field of PNH to share the latest research, advancements, and insights. The 2nd International PNH Interest Group (IPIG) Conference is taking place in Paris, France, on May 15-16, 2025. This meeting will bring together leading experts in the field of PNH to share the latest research, advancements, and insights. We use cookies to provide the
Source: www.vjhemonc.comCategories: General Medicine NewsTweet-
Wrapping up our first IPIG meeting by speaking to @AustinKulasekar โ this interview is not one to be missed!๐ฅ We've had some fantastic conversations with PNH experts today, and we've already started sharing them on our site ๐https://t.co/OJLIzhs6Qk There's lots more to come https://t.co/5mMhHTllzX
-
-
Mashup Score: 0Gene therapy in sickle cell disease: patient selection, potential complications, & more - 1 day(s) ago
In this episode of the VJHemOnc podcast you will hear from Akshay Sharma, MBBS, MSc, St. Jude Childrenโs Research Hospital,…
Source: www.vjhemonc.comCategories: General Medicine NewsTweet-
Will gene therapy transform the future of #SickleCellDisease care?๐ฉธ๐งฌ We've just published a podcast episode in which @AkshaySharmaMD provides valuable insights into this therapeutic approach. Donโt miss it! ๐ง๐๏ธ Listen here: ๐ https://t.co/ZNeFZJpDwA #Hematology https://t.co/CBx2M2c0Be
-
-
Mashup Score: 1VJHemOnc โ The video journal of hematological oncology - 1 day(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet-
#SOHO2023 is taking place next week in Houston, TX!๐ We @VJHemOnc are looking forward to interviewing and sharing the latest in #Leukemia, #Lymphoma and more. Follow us and check out https://t.co/O9p0vDBrzw to stay updated! @SocietyofHemOnc #LeuSM #LymSM #MMsm #MDSsm #MPNsm https://t.co/cQo18FkF3a
-
-
Mashup Score: 2VJHemOnc - Ask the expert: LIVE at EHA 2025 - 1 day(s) ago
We’re bringing your questions straight to leading hematology experts during our Ask the Expert sessions, filmed from the EHA 2025 Congress, at the VJHemOnc booth (B.01). Submit the questions youโd like answered on key topics in hematology. Selected submissions will be answered on camera and featured across VJHemOncโs platforms.
Source: docs.google.comCategories: General Medicine NewsTweet-
We're bringing your questions straight to leading #HemOnc experts during our Ask the Expert sessions, filmed at our #EHA2025 booth๐๐ฅ๐ฉธ Barbara Eichhorst @DrRakeshPopat & @AnnaSureda5 To submit a question reply here, send us a DM or fill in this form ๐ https://t.co/7gi4ikVt2R https://t.co/R7pw0zSxHm
-
-
Mashup Score: 0
Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, comments on the current state of next-generation CAR constructs in multiple myeloma (MM), highlighting some constructs she believes hold promise for treating this malignancy. Several dual-targeting CAR strategies are being investigated to improve upon the outcomes achieved with currently available CAR T-cell products. Dr Raje also mentions anitocabtagene autoleucel (anito-cel), an autologous anti-BCMA CAR T-cell therapy with a novel synthetic D-domain binder, which is being investigated in the Phase III iMMagine-3 (NCT06413498) clinical trial. This interview took place at the 11th World Congress on Controversies in Multiple Myeloma (COMy) congress in Paris, France. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Source: www.vjhemonc.comCategories: General Medicine NewsTweet
-
Mashup Score: 0Switching from C5 inhibition to proximal inhibition in PNH: selecting the right treatment approach - 2 day(s) ago
Jens Panse, MD, Aachen University Hospital, Aachen, Germany, discusses the complexities of switching patients with paroxysmal nocturnal hemoglobinuria (PNH) from C5 inhibitors to proximal complement inhibitors. Dr Panse emphasizes the importance of personalized medicine when deciding which patients might benefit from a switch, particularly after 12 months on C5 inhibition. This interview took place at the 2nd International PNH Interest Group (IPIG) Conference in Paris, France. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Source: www.vjhemonc.comCategories: General Medicine NewsTweet
-
Mashup Score: 13COMy 2025 | VJHemOnc - 2 day(s) ago
The 11th World Congress on Controversies in Multiple Myeloma (COMy) took place on May 15-18, 2025, in Paris, France. Leading researchers congregated at this meeting to discuss the latest advances in the scientific understanding and clinical treatment of multiple myeloma. The 11th World Congress on Controversies in Multiple Myeloma (COMy) took place on May 15-18, 2025, in Paris, France. Leading researchers congregated at this meeting to discuss the latest advances in the scientific understanding and
Source: www.vjhemonc.comCategories: General Medicine NewsTweet-
We wanted to say a big thank you to the organizers of #COMy2025 for having us onsite last week!๐ As always, it was a pleasure to attend and to be official media partners for the event.๐ฅ๐ฉธ Explore our exclusive coverage here: ๐ https://t.co/u8X7mYAVx8 #MMSM @COMyCongress https://t.co/EskB8JXeBP
-
-
Mashup Score: 9
Join us to watch leading MM experts present summaries on the most significant abstracts from EHA 2025 followed by interactive panel discussions debating current clinical issues. Chaired by Dr Faith Davies with co-moderators Dr Charlotte Pawlyn and Dr Ciara Freeman. Webinar attendees will be given the opportunity to send in their questions where they will be answered during the live panel discussions. *Please note* This webinar is for HCPs and allied health professionals only. Your application to attend will be reviewed and confirmed by VJHemOnc.
Source: us06web.zoom.usCategories: General Medicine NewsTweet
-
Mashup Score: 2Highlights from iwCAR-T 2025: improving the efficacy and safety of CAR T-cells & access in the community - 3 day(s) ago
Todayโs VJHemOnc podcast features discussions from the 7th International Workshop on CAR-T and bispecifics (iwCAR-T) 2025, which was held recently…
Source: www.vjhemonc.comCategories: General Medicine NewsTweet
#SOHO2023 is taking place next week in Houston, TX!๐ We @VJHemOnc are looking forward to interviewing and sharing the latest in #Leukemia, #Lymphoma and more. Follow us and check out https://t.co/O9p0vDBrzw to stay updated! @SocietyofHemOnc #LeuSM #LymSM #MMsm #MDSsm #MPNsm https://t.co/cQo18FkF3a